Cargando…
A Handling Study to Assess Use of the Respimat(®) Soft Mist™ Inhaler in Children Under 5 Years Old
Background: Respimat(®) Soft Mist™ Inhaler (SMI) is a hand-held device that generates an aerosol with a high, fine-particle fraction, enabling efficient lung deposition. The study objective was to assess inhalation success among children using Respimat SMI, and the requirement for assistance by the...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601632/ https://www.ncbi.nlm.nih.gov/pubmed/25844687 http://dx.doi.org/10.1089/jamp.2014.1159 |
_version_ | 1782394572745211904 |
---|---|
author | Kamin, Wolfgang Frank, Marion Kattenbeck, Sabine Moroni-Zentgraf, Petra Wachtel, Herbert Zielen, Stefan |
author_facet | Kamin, Wolfgang Frank, Marion Kattenbeck, Sabine Moroni-Zentgraf, Petra Wachtel, Herbert Zielen, Stefan |
author_sort | Kamin, Wolfgang |
collection | PubMed |
description | Background: Respimat(®) Soft Mist™ Inhaler (SMI) is a hand-held device that generates an aerosol with a high, fine-particle fraction, enabling efficient lung deposition. The study objective was to assess inhalation success among children using Respimat SMI, and the requirement for assistance by the parent/caregiver and/or a valved holding chamber (VHC). Methods: This open-label study enrolled patients aged <5 years with respiratory disease and history of coughing and/or recurrent wheezing. Patients inhaled from the Respimat SMI (air only; no aerosol) using a stepwise configuration: “1” (dose released by child); “2” (dose released by parent/caregiver), and “3” (Respimat SMI with VHC, facemask, and parent/caregiver help). Co-primary endpoints included the ability to perform successful inhalation as assessed by the investigators using a standardized handling questionnaire and evaluation of the reasons for success. Inhalation profile in the successful handling configuration was verified with a pneumotachograph. Patient satisfaction and preferences were investigated in a questionnaire. Results: Of the children aged 4 to <5 years (n=27) and 3 to <4 years (n=30), 55.6% and 30.0%, respectively, achieved success without a VHC or help; with assistance, another 29.6% and 10.0%, respectively, achieved success, and the remaining children were successful with VHC. All children aged 2 to <3 years (n=20) achieved success with the Respimat SMI and VHC. Of those aged <2 years (n=22), 95.5% had successful handling of the Respimat SMI with VHC and parent/caregiver help. Inhalation flow profiles generally confirmed the outcome of the handling assessment by the investigators. Most parent/caregiver and/or child respondents were satisfied with operation, instructions for use, handling, and ease of holding the Respimat SMI with or without a VHC. Conclusions: The Respimat SMI is suitable for children aged <5 years; however, children aged <5 years are advised to add a VHC to complement its use. |
format | Online Article Text |
id | pubmed-4601632 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Mary Ann Liebert, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-46016322015-10-20 A Handling Study to Assess Use of the Respimat(®) Soft Mist™ Inhaler in Children Under 5 Years Old Kamin, Wolfgang Frank, Marion Kattenbeck, Sabine Moroni-Zentgraf, Petra Wachtel, Herbert Zielen, Stefan J Aerosol Med Pulm Drug Deliv Original Research Background: Respimat(®) Soft Mist™ Inhaler (SMI) is a hand-held device that generates an aerosol with a high, fine-particle fraction, enabling efficient lung deposition. The study objective was to assess inhalation success among children using Respimat SMI, and the requirement for assistance by the parent/caregiver and/or a valved holding chamber (VHC). Methods: This open-label study enrolled patients aged <5 years with respiratory disease and history of coughing and/or recurrent wheezing. Patients inhaled from the Respimat SMI (air only; no aerosol) using a stepwise configuration: “1” (dose released by child); “2” (dose released by parent/caregiver), and “3” (Respimat SMI with VHC, facemask, and parent/caregiver help). Co-primary endpoints included the ability to perform successful inhalation as assessed by the investigators using a standardized handling questionnaire and evaluation of the reasons for success. Inhalation profile in the successful handling configuration was verified with a pneumotachograph. Patient satisfaction and preferences were investigated in a questionnaire. Results: Of the children aged 4 to <5 years (n=27) and 3 to <4 years (n=30), 55.6% and 30.0%, respectively, achieved success without a VHC or help; with assistance, another 29.6% and 10.0%, respectively, achieved success, and the remaining children were successful with VHC. All children aged 2 to <3 years (n=20) achieved success with the Respimat SMI and VHC. Of those aged <2 years (n=22), 95.5% had successful handling of the Respimat SMI with VHC and parent/caregiver help. Inhalation flow profiles generally confirmed the outcome of the handling assessment by the investigators. Most parent/caregiver and/or child respondents were satisfied with operation, instructions for use, handling, and ease of holding the Respimat SMI with or without a VHC. Conclusions: The Respimat SMI is suitable for children aged <5 years; however, children aged <5 years are advised to add a VHC to complement its use. Mary Ann Liebert, Inc. 2015-10-01 /pmc/articles/PMC4601632/ /pubmed/25844687 http://dx.doi.org/10.1089/jamp.2014.1159 Text en © The Author(s) 2015; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Original Research Kamin, Wolfgang Frank, Marion Kattenbeck, Sabine Moroni-Zentgraf, Petra Wachtel, Herbert Zielen, Stefan A Handling Study to Assess Use of the Respimat(®) Soft Mist™ Inhaler in Children Under 5 Years Old |
title | A Handling Study to Assess Use of the Respimat(®) Soft Mist™ Inhaler in Children Under 5 Years Old |
title_full | A Handling Study to Assess Use of the Respimat(®) Soft Mist™ Inhaler in Children Under 5 Years Old |
title_fullStr | A Handling Study to Assess Use of the Respimat(®) Soft Mist™ Inhaler in Children Under 5 Years Old |
title_full_unstemmed | A Handling Study to Assess Use of the Respimat(®) Soft Mist™ Inhaler in Children Under 5 Years Old |
title_short | A Handling Study to Assess Use of the Respimat(®) Soft Mist™ Inhaler in Children Under 5 Years Old |
title_sort | handling study to assess use of the respimat(®) soft mist™ inhaler in children under 5 years old |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601632/ https://www.ncbi.nlm.nih.gov/pubmed/25844687 http://dx.doi.org/10.1089/jamp.2014.1159 |
work_keys_str_mv | AT kaminwolfgang ahandlingstudytoassessuseoftherespimatsoftmistinhalerinchildrenunder5yearsold AT frankmarion ahandlingstudytoassessuseoftherespimatsoftmistinhalerinchildrenunder5yearsold AT kattenbecksabine ahandlingstudytoassessuseoftherespimatsoftmistinhalerinchildrenunder5yearsold AT moronizentgrafpetra ahandlingstudytoassessuseoftherespimatsoftmistinhalerinchildrenunder5yearsold AT wachtelherbert ahandlingstudytoassessuseoftherespimatsoftmistinhalerinchildrenunder5yearsold AT zielenstefan ahandlingstudytoassessuseoftherespimatsoftmistinhalerinchildrenunder5yearsold AT kaminwolfgang handlingstudytoassessuseoftherespimatsoftmistinhalerinchildrenunder5yearsold AT frankmarion handlingstudytoassessuseoftherespimatsoftmistinhalerinchildrenunder5yearsold AT kattenbecksabine handlingstudytoassessuseoftherespimatsoftmistinhalerinchildrenunder5yearsold AT moronizentgrafpetra handlingstudytoassessuseoftherespimatsoftmistinhalerinchildrenunder5yearsold AT wachtelherbert handlingstudytoassessuseoftherespimatsoftmistinhalerinchildrenunder5yearsold AT zielenstefan handlingstudytoassessuseoftherespimatsoftmistinhalerinchildrenunder5yearsold |